Jun 30, 2024

Assertio Q2 2024 Earnings Report

Reported financial results for the second quarter ended June 30, 2024.

Key Takeaways

Assertio Holdings reported second quarter net product sales of $30.7 million. Rolvedon's growth continued with $15.1 million in net product sales. The company generated $7.4 million in cash flow from operations, and cash and short-term investments increased to $88.4 million.

Total net product sales were $30.7 million.

Rolvedon net product sales increased to $15.1 million.

Indocin net product sales were $6.9 million.

Cash, cash equivalents and short-term investments increased to $88.4 million.

Total Revenue
$31.1M
Previous year: $41M
-24.1%
EPS
$0.02
Previous year: $0.19
-89.5%
Adjusted EBITDA
$5M
Previous year: $24.8M
-79.8%
Gross Profit
$22.2M
Previous year: $35.3M
-37.0%
Cash and Equivalents
$44.7M
Previous year: $70.2M
-36.3%
Free Cash Flow
$7.39M
Previous year: $18.1M
-59.1%
Total Assets
$279M
Previous year: $405M
-31.0%

Assertio

Assertio

Forward Guidance

Assertio reiterated its 2024 operating guidance as announced on March 11, 2024.

Positive Outlook

  • Net Product Sales (GAAP) $110.0 Million to $125.0 Million
  • Adjusted EBITDA (Non-GAAP) $20.0 Million to $30.0 Million